Check out market updates

Clovis Oncology stock soars 40% in early trading on positive Phase III data

BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS) said the top-line data of its Phase III trial showed that its flagship […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *